# Efficacy and Safety Study of Desloratadine (MK-4117) in Japanese Participants With Seasonal Allergic Rhinitis (MK-4117-204)

> **NCT02320396** · PHASE3 · COMPLETED · sponsor: **Organon and Co** · enrollment: 449 (actual)

## Conditions studied

- Seasonal Allergic Rhinitis

## Interventions

- **DRUG:** Desloratadine 5 mg
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT02320396
- **Lead sponsor:** Organon and Co
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-01-09
- **Primary completion:** 2015-04-27
- **Final completion:** 2015-04-27
- **Target enrollment:** 449 (ACTUAL)
- **Last updated:** 2024-05-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02320396

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02320396, "Efficacy and Safety Study of Desloratadine (MK-4117) in Japanese Participants With Seasonal Allergic Rhinitis (MK-4117-204)". Retrieved via AI Analytics 2026-06-04 from https://api.ai-analytics.org/clinical/NCT02320396. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*